MAIPA Workshop
Thursday March 3rd, 2021 (14:00 – 16:00) Our goal is to exchange experiences with the MAIPA technology and platelet serology in general and to r...
apDia > News room
Reliable testing of COVID-19 and Influenza with RIDA®GENE Flu & SARS-CoV-2. ( also for new SARS-CoV-2 variant)
Qualitative detection and differentiation of Influenza A/B (M gene/NP1 gene) and SARS-CoV-2 (E gene; RdRp gene) respiratory sample material. Reliable:...
Dynex automated open systems
Also during the COVID-19 pandemic, the technical people from apDia keep on working very hard, taking into account all safety regulations. This week, t...
Meet Ms. Eliana De Sousa Salgado
Eliana will be responsible for Marketing & Sales/Product support at the Netherlands. She’s already working for many years at the labs of apD...
apDia ( Belgium) is rated as one of the Major Key Players for TDM
Therapeutic drug monitoring (TDM) plays a significant role in clinical decision-making and is rapidly becoming an essential and specialized element of...
Eflexis goes to The Netherlands
After the successes in Belgium. apDia installed the first Grifols Eflexis blood group analysers in the laboratories at the Netherlands. The Erytra Efl...
Comparison of Commercial RT-PCR diagnostic kits for COVID-19
In a report from the National Institute of Public Health and the Environment in the Netherlands , R-biopharm’s RIDA®GENE SARS-CoV-2 RT-PCR kit,...
Real-time RT-PCR Test for detection of Coronavirus
R-Biopharm launches as one of the first companies a real-time RT-PCR test for the detection of current coronavirus species As an innovative company we...
New year, new installation Erytra Eflexis from Grifols
Also in 2020 , apDia continues to install Grifols’ blood group analysers in Belgium laboratories. The Erytra Eflexis® (Grifols) is a new fully a...